Monitoring preeclampsia patients
Colorimetric Assay
Magnesium (Mg)
Mg (Magnesium)
Serum
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.5 mL
Collection Instructions:
1. See Metals Analysis Specimen Collection and Transport for complete instructions.
2. Serum gel tubes should be centrifuged within 2 hours of collection.
3. Red-top tubes should be centrifuged and aliquoted within 2 hours of collection.
Additional Information: If other metal tests are also desired when drawing for a serum magnesium level; the specimen must be drawn in a plain, royal blue-top Vacutainer plastic trace element blood collection tube.
0.25 mL
Gross hemolysis | Reject |
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 365 days |
Monitoring preeclampsia patients
Magnesium, along with potassium, is a major intracellular cation. Magnesium is a cofactor of many enzyme systems. All adenosine triphosphate (ATP)-dependent enzymatic reactions require magnesium as a cofactor. Approximately 70% of magnesium ions are stored in bone. The remainder is involved in intermediary metabolic processes; about 70% is present in free form while the other 30% is bound to proteins (especially albumin), citrates, phosphate, and other complex formers. The serum magnesium level is kept constant within very narrow limits. Regulation takes place mainly via the kidneys, primarily via the ascending loop of Henle.
Conditions that interfere with glomerular filtration result in retention of magnesium and, hence, elevation of serum concentrations. Hypermagnesemia is found in acute and chronic renal failure, magnesium overload, and magnesium release from the intracellular space. Mild-to-moderate hypermagnesemia may prolong atrioventricular conduction time. Magnesium toxicity may result in central nervous system (CNS) depression, cardiac arrest, and respiratory arrest.
Numerous studies have shown a correlation between magnesium deficiency and changes in calcium, potassium, and phosphate homeostasis, which are associated with cardiac disorders such as ventricular arrhythmias that cannot be treated by conventional therapy, increased sensitivity to digoxin, coronary artery spasms, and sudden death. Additional concurrent symptoms include neuromuscular and neuropsychiatric disorders. Conditions that have been associated with hypomagnesemia include chronic alcoholism, childhood malnutrition, lactation, malabsorption, acute pancreatitis, hypothyroidism, chronic glomerulonephritis, aldosteronism, and prolonged intravenous feeding.
0-2 years: 1.6-2.7 mg/dL
3-5 years: 1.6-2.6 mg/dL
6-8 years: 1.6-2.5 mg/dL
9-11 years: 1.6-2.4 mg/dL
12-17 years: 1.6-2.3 mg/dL
>17 years: 1.7-2.3 mg/dL
Symptoms of magnesium deficiency do not typically appear until levels are 1.0 mg/dL or lower.
Levels of 9.0 mg/dL or higher may be life-threatening.
Serum or plasma magnesium concentration provides only an
1. Tietz Textbook of Clinical Chemistry. Chapter 49: Fourth edition. Edited by CA Burtis, ER Ashwood, DE Bruns. Philadelphia, WB Saunders Company, 2006, pp 1893-1912
2. Ryan MF: The role of magnesium in clinical biochemistry: an overview. Ann Clin Biochem 1991;28:19-26
In an alkaline solution, magnesium forms a purple complex with xylidyl
Monday through Sunday
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
83735
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
MGS | Magnesium, S | 19123-9 |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
MGS | Magnesium, S | 19123-9 |